Found: 9
Select item for more details and to access through your institution.
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis : Efficacy and long-term safety in a single institution.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis.
- Published in:
- 2012
- By:
- Publication type:
- Report
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 8, p. 1039, doi. 10.1093/neuonc/noz088
- By:
- Publication type:
- Article
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin’s Lymphoma.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 11, p. 719, doi. 10.2165/00044011-200525110-00005
- By:
- Publication type:
- Article
Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 400, doi. 10.1002/hon.2996
- By:
- Publication type:
- Article
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E52, doi. 10.1002/ajh.24981
- By:
- Publication type:
- Article
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 511, doi. 10.1002/ajh.23999
- By:
- Publication type:
- Article
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1024, doi. 10.1002/ajh.23812
- By:
- Publication type:
- Article